Growth regulatory functions of IL6 and antitumour effects
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 143 (7) , 769-773
- https://doi.org/10.1016/0923-2494(92)80021-c
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Interleukin‐6 production by the blast cells of acute myeloblastic leukemia: Regulation by endogenous interleukin‐1 and biological implicationsJournal of Cellular Physiology, 1991
- Interleukin-6 and 12-O-tetradecanoyl Phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cellsCytokine, 1991
- Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastasesInternational Journal of Cancer, 1990
- Antitumor activity of recombinant interleukin 6 in mice.The Journal of Experimental Medicine, 1990
- Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSFInternational Journal of Cancer, 1990
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- Host defense against infections and inflammations: Role of the multifunctional IL-6/IFN-β2 cytokineCellular and Molecular Life Sciences, 1989
- Recombinant interferon‐β2 (interleukin‐6) induces myeloid differentiationFEBS Letters, 1988
- Recombinant human interleukin 6 (B‐cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1)FEBS Letters, 1988